Academia or Startup? Talk w/ Omri Amirav-Drory of NFX
Join NFX and Biotech@Berkeley for an exciting talk on Monday, 3/16. There will be refreshments and food!
Potential scientist-founders often face the choice between pursuing a career in academia or industry versus starting their own company. Omri Amirav-Drory, PhD (General Partner at NFX) will be sharing his unique journey from the bench to the boardroom, offering candid insights into the dynamic intersection of science, entrepreneurship, and investment
Who Should Attend? Calling all Berkeley students and staff in the areas of biology, chemistry, biotechnology, computational biology, molecular biology and related fields! Whether you’re pursuing an undergraduate degree, MS, MBA, MET, PhD, or engaged in postdoc research, this event aims to inspire and answer questions about starting your own techbio company.
Have an idea or currently building something? The NFX FAST Initiative is live. Apply by 4/12 for a $150K Uncapped SAFE or $1-3M SAFE for 15%. It's an opportunity to secure funding for your startup through a simple, application-driven process. Founders who receive funding join the NFX guild (our vast portfolio and network of 400+ supportive founders) and get mentorship from the NFX team.
More info can be found at: https://fast.nfx.com/berkeley-fast-2026
Location: Room N100, Chou Hall - Berkeley Haas
About NFX: NFX is one of the largest pre-seed/seed VC firms in the world with ~$1.5B in AUM. Partners have built 10 companies worth >$10 billion, and NFX is proud to have invested in 250+ companies including Trulia, Lyft, DoorDash, Poshmark, Patreon, Mammoth Biosciences, and Twist Biosciences.